---
title: "MNMD.US (MNMD.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/MNMD.US/news.md"
symbol: "MNMD.US"
name: "MNMD.US"
parent: "https://longbridge.com/zh-CN/quote/MNMD.US.md"
datetime: "2026-03-13T21:03:30.228Z"
locales:
  - [en](https://longbridge.com/en/quote/MNMD.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MNMD.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MNMD.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/MNMD.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MNMD.US/news.md)


# MNMD.US (MNMD.US) — 相关新闻

### [NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease](https://longbridge.com/zh-CN/news/278712431.md)
*2026-03-11T11:30:02.000Z*
> NeuroThera Labs Inc. has announced the publication of an international patent in collaboration with Clearmind Medicine f

### [InSilico Medicine Expects 2025 Losses to Widen; Shares Gain 4%](https://longbridge.com/zh-CN/news/278327366.md)
*2026-03-09T04:45:25.000Z*
> InSilico Medicine Expects 2025 Losses to Widen; Shares Gain 4%

### [MiniMed Group Shares Fall After Nasdaq Debut](https://longbridge.com/zh-CN/news/278149148.md)
*2026-03-06T18:10:42.000Z*
> MiniMed Group Shares Fall After Nasdaq Debut

### [New progress in psychedelic drug treatment for depression: faster effects than traditional medications](https://longbridge.com/zh-CN/news/277846503.md)
*2026-03-04T23:22:42.000Z*
> Psychedelics have made new progress in the treatment of severe depression, showing faster efficacy than traditional medi

### [MedWellAI, Inc. SEC 10-Q Report](https://longbridge.com/zh-CN/news/276638041.md)
*2026-02-23T19:41:01.000Z*
> MedWellAI, Inc. has released its Form 10-Q report for Q4 2025, indicating a strategic shift from digital asset mining to

### [Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial  | CMND Stock News](https://longbridge.com/zh-CN/news/275323523.md)
*2026-02-09T05:17:00.000Z*
> Clearmind Medicine Inc. announced positive safety results from its ongoing Phase I/IIa clinical trial for CMND-100, a no

### [Clearmind Medicine partners to develop intranasal MEAI for addiction & CNS disorders, boosting bioavailability & clinical progress.](https://longbridge.com/zh-CN/news/275130893.md)
*2026-02-06T12:56:00.000Z*
> Partnership established to improve absorption and aid in the progression of Clearmind's primary MEAI drug for addiction 

### [Clearmind Medicine erzielt Durchbruch mit MEAI in US-Gesetz für innovative Veteranen-Therapien](https://longbridge.com/zh-CN/news/274659830.md)
*2026-02-03T13:01:03.000Z*
### [LSD therapy biotech Definium sued for alleged trade secret theft](https://longbridge.com/zh-CN/news/274563320.md)
*2026-02-02T22:05:18.000Z*
### [Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Short Interest Update](https://longbridge.com/zh-CN/news/273028939.md)
*2026-01-20T04:19:23.000Z*
> Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) experienced a 19.4% increase in short interest in December, totaling 15,054,6